儿童及青少年甲状腺癌诊治的挑战与机遇

doi:10.16139/j.1007-9610.2023.06.02

摘要/Abstract

摘要：

儿童及青少年甲状腺癌是一类特殊类型的甲状腺癌，受到越来越广泛的重视。近年来，针对这一疾病的认识，疑点和难点不断浮现。本文将对这些临床挑战作一综述，总结国内外近期研究进展，以期发现更多提升儿童及青少年甲状腺癌诊治水平的宝贵机遇。

Abstract:

Thyroid carcinoma in children and young adolescent is a special type of thyroid carcinoma, which has received more and more attention. In recent years, confusion and difficulties continue to emerge in understanding the disease. This article reviewed these clinical challenges and summarized recent research progress at home and abroad, with a view to identifying valuable opportunities to improve the diagnosis and treatment of thyroid carcinoma in children and young adolescents.

Key words: Children, Young adolescent, Thyroid carcinoma

中图分类号:

王卓颖, 史苑, 郭凯, 钱凯. 儿童及青少年甲状腺癌诊治的挑战与机遇[J]. 外科理论与实践, 2023, 28(06): 496-500.

WANG Zhuoying, SHI Yuan, GUO Kai, QIAN Kai. Challenges and opportunities in the diagnosis and treatment of thyroid carcinoma in children and young adolescents[J]. Journal of Surgery Concepts & Practice, 2023, 28(06): 496-500.

参考文献 38

[1]	王卓颖, 史苑, 郭凯, 等. 青少年分化型甲状腺癌的诊治:从陌生到规范[J]. 外科理论与实践, 2021, 26(6):497-499.
	WANG Z Y, SHI Y, GUO K, et al. Diagnosis and treatment of differentiated thyroid cancer in adolescents: from unfamiliarity to standardization[J]. J Surg Concepts Pract, 2021, 26(6):497-499.
[2]	GUO K, QIAN K, SHI Y, et al. Clinical and molecular characterizations of papillary thyroid cancer in children and young adults: a multicenter retrospective study[J]. Thyroid, 2021, 31(11):1693-1706. doi: 10.1089/thy.2021.0003 pmid: 34514877
[3]	VAN DE BERG D J, KUIJPERS A M J, ENGELSMAN A F, et al. Long-term oncological outcomes of papillary thyroid cancer and follicular thyroid cancer in children: a nationwide population-based study[J]. Front Endocrinol (Lausanne), 2022, 13:899506. doi: 10.3389/fendo.2022.899506 URL
[4]	WEBER T, HUMMEL R, VORLÄNDER C, et al. Thyroid surgery in children and adolescents: results from a multi-institutional German and Austrian database[J]. Br J Surg, 2023, 110(12):1808-1814. doi: 10.1093/bjs/znad255 URL
[5]	中国临床肿瘤学会. 中国临床肿瘤学会甲状腺髓样癌诊疗指南[M]. 北京: 人民卫生出版社, 2022.
	Chinese Society of Clinical Oncology. Diagnosis and treatment guidelines for medullary thyroid carcinoma of the Chinese Society of Clinical Oncology[M]. Beijing People's Health Publishing House, 2022.
[6]	HALADA S, BARAN J A, BAUER A J, et al. Clinicopathologic characteristics of pediatric follicular variant of papillary thyroid carcinoma subtypes: a retrospective cohort study[J]. Thyroid, 2022, 32(11):1353-1361. doi: 10.1089/thy.2022.0239 pmid: 36103376
[7]	KIM S Y, YUN H J, CHANG H, et al. Aggressiveness of differentiated thyroid carcinoma in pediatric patients younger than 16 years: a propensity score-matched analysis[J]. Front Oncol, 2022, 12:872130. doi: 10.3389/fonc.2022.872130 URL
[8]	THIESMEYER J W, EGAN C E, GREENBERG J A, et al. Prepubertal children with papillary thyroid carcinoma present with more invasive disease than adolescents and young adults[J]. Thyroid, 2023, 33(2):214-222. doi: 10.1089/thy.2022.0098 URL
[9]	SUGINO K, NAGAHAMA M, KITAGAWA W, et al. Cutoff age between pediatric and adult thyroid differentiated cancer: is 18 years old appropriate?[J]. Thyroid, 2022, 32(2):145-152. doi: 10.1089/thy.2021.0255 URL
[10]	DA SILVA BREDER J R A, ALVES P A G, ARAÚJO M L, et al. Puberty and sex in pediatric thyroid cancer: could expression of estrogen and progesterone receptors affect prognosis?[J]. Eur Thyroid J, 2022, 11(2):e210090.
[11]	STOSIC A, FULIGNI F, ANDERSON N D, et al. Diverse oncogenic fusions and distinct gene expression patterns define the genomic landscape of pediatric papillary thyroid carcinoma[J]. Cancer Res, 2021, 81(22):5625-5637. doi: 10.1158/0008-5472.CAN-21-0761 pmid: 34535459
[12]	NIES M, VASSILOPOULOU-SELLIN R, BASSETT R L, et al. Distant metastases from childhood differentiated thyroid carcinoma: clinical course and mutational landscape[J]. J Clin Endocrinol Metab, 2021, 106(4):e1683-e1697. doi: 10.1210/clinem/dgaa935 pmid: 33382403
[13]	LEE Y A, LEE H, IM S W, et al. NTRK and RET fusion-directed therapy in pediatric thyroid cancer yields a tumor response and radioiodine uptake[J]. J Clin Invest, 2021, 131(18):e144847. doi: 10.1172/JCI144847 URL
[14]	LI H, HAN R, MENG L, et al. Nodal metastases associa-ted with fusion oncogenes are age dependent in young adult patients with thyroid cancer[J]. J Clin Endocrinol Metab, 2023, 109(1):143-150. doi: 10.1210/clinem/dgad458 URL
[15]	XING Z, QIU Y, ZHU J, et al. Diagnostic performance of adult-based ultrasound risk stratification systems in pe-diatric thyroid nodules: a systematic review and meta-analysis[J]. Front Endocrinol (Lausanne), 2023, 14:1187935. doi: 10.3389/fendo.2023.1187935 URL
[16]	TULI G, MUNARIN J, SCOLLO M, et al. Evaluation of the efficacy of EU-TIRADS and ACR-TIRADS in risk stratification of pediatric patients with thyroid nodules[J]. Front Endocrinol (Lausanne), 2022, 13:1041464. doi: 10.3389/fendo.2022.1041464 URL
[17]	Ren P Y, Liu J, Xue S, et al. Pediatric differentiated thyroid carcinoma: the clinicopathological features and the coexistence of Hashimoto's thyroiditis[J]. Asian J Surg, 2019, 42(1):112-119. doi: 10.1016/j.asjsur.2017.10.006 URL
[18]	WON J H, LEE J Y, HONG H S, et al. Thyroid nodules and cancer in children and adolescents affected by Hashimoto's thyroiditis[J]. Br J Radiol, 2018, 91(1087):20180014.
[19]	YANG J, PAGE L C, WAGNER L, et al. Thyroid nodules on ultrasound in children and young adults: comparison of diagnostic performance of radiologists' impressions, ACR TI-RADS, and a deep learning algorithm[J]. Am J Roentgenol, 2023, 220(3):408-417. doi: 10.2214/AJR.22.28231 URL
[20]	VAN ROOIJEN J J, VAN TROTSENBURG A S P, VAN DE BERG D J, et al. Complications after thyroidectomy in children: lymph node dissection is a risk factor for permanent hypocalcemia[J]. Front Endocrinol (Lausanne), 2021, 12:717769. doi: 10.3389/fendo.2021.717769 URL
[21]	MAKSIMOSKI M, BAUER A J, KAZAHAYA K, et al. Outcomes in pediatric thyroidectomy: results from a multinational, multi-institutional database[J]. Otolaryngol Head Neck Surg, 2022, 167(5):869-876. doi: 10.1177/01945998221076065 URL
[22]	WU S Y, CHIANG Y J, FISHER S B, et al. Risks of hypoparathyroidism after total thyroidectomy in children: a 21-year experience in a high-volume cancer center[J]. World J Surg, 2020, 44(2):442-451. doi: 10.1007/s00268-019-05231-4 URL
[23]	ZOBEL M J, LONG R, GOSNELL J, et al. Postoperative hypoparathyroidism after total thyroidectomy in children[J]. J Surg Res, 2020, 252:63-68. doi: S0022-4804(20)30115-3 pmid: 32234570
[24]	SPINELLI C, GHIONZOLI M, BERTOCCHINI A, et al. Factors associated with postoperative hypocalcemia following thyroidectomy in childhood[J]. Pediatr Blood Cancer, 2022, 69(8):e29576. doi: 10.1002/pbc.v69.8 URL
[25]	DEKKER B L, MULLER KOBOLD A C, BROUWERS A H, et al. Bone mineral density in adult survivors of pediatric differentiated thyroid carcinoma: a longitudinal follow-up study[J]. Thyroid, 2021, 31(11):1707-1714. doi: 10.1089/thy.2021.0179 pmid: 34514857
[26]	中国临床肿瘤学会核医学专家委员会, 中国临床肿瘤学会甲状腺癌专家委员会, 中国医疗保健国际交流促进会甲状腺疾病专业委员会, 等. 儿童及青少年分化型甲状腺癌核医学诊治中国专家共识(2022年版)[J]. 中国癌症杂志, 2022, 32(5):451-468. doi: 10.19401/j.cnki.1007-3639.2022.05.011
	The Nuclear Medicine Expert Committee of the Chinese Society of Clinical Oncology, The Thyroid Cancer Expert Committee of the Chinese Society of Clinical Oncology, The Thyroid Disease Professional Committee of the China Association for International Exchange and Promotion of Healthcare, et al. Expert consensus on management of differentiated thyroid carcinoma in children and adolescents (2022 edition)[J]. China Oncol, 2022, 32(5):451-468.
[27]	KUMAR P, DAMLE N A, BAL C. Radioiodine therapy in pediatric differentiated thyroid cancer: dosimetry, clinical care, and future challenges[J]. Clin Nucl Med, 2023, 48(2):158-167. doi: 10.1097/RLU.0000000000004431 URL
[28]	BOJARSKY M, BARAN J A, HALADA S, et al. Outcomes of ATA low-risk pediatric thyroid cancer patients not treated with radioactive iodine therapy[J]. J Clin Endocrinol Metab, 2023, 108(12):3338-3344. doi: 10.1210/clinem/dgad322 pmid: 37265226
[29]	PASQUAL E, SCHONFELD S, MORTON L M, et al. Association between radioactive iodine treatment for pedia-tric and young adulthood differentiated thyroid cancer and risk of second primary malignancies[J]. J Clin Oncol, 2022, 40(13):1439-1449. doi: 10.1200/JCO.21.01841 URL
[30]	LEBBINK C A, VAN SANTEN H M, DANEMAN A, et al. Does ultrasound really contribute to detection of residual/recurrent disease after pediatric thyroidectomy? Preliminary data supporting a "thyroglobulin-first" approach[J]. Thyroid, 2023, 33(5):645-649. doi: 10.1089/thy.2022.0576 pmid: 37014072
[31]	MAJEED A K, SATAPATHY S, BALLAL S, et al. Dynamic risk stratification for predicting long-term outcomes in pediatric differentiated thyroid cancers[J]. J Clin Endocrinol Metab, 2023, 108(6):e208-e215. doi: 10.1210/clinem/dgac731 URL
[32]	REDLICH A, LUSTER M, LORENZ K, et al. Age, American Thyroid Association Risk Group, and response to therapy are prognostic factors in children with differentiated thyroid cancer[J]. J Clin Endocrinol Metab, 2022, 107(1):e165-e177. doi: 10.1210/clinem/dgab622 URL
[33]	WIRTH L J, SHERMAN E, ROBINSON B, et al. Efficacy of selpercatinib in RET-altered thyroid cancers[J]. N Engl J Med, 2020, 383(9):825-835. doi: 10.1056/NEJMoa2005651 URL
[34]	HONG D S, DUBOIS S G, KUMMAR S, et al. Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials[J]. Lancet Oncol, 2020, 21(4):531-540. doi: S1470-2045(19)30856-3 pmid: 32105622
[35]	WAGUESPACK S G, TEWARI S O, BUSAIDY N L, et al. Larotrectinib before initial radioactive iodine therapy in pediatric TRK fusion-positive papillary thyroid carcinoma: time to reconsider the treatment paradigm for distantly metastatic disease?[J]. JCO Precis Oncol, 2022, 6:e2100467.
[36]	CHEN D Q, ZHOU E Q, CHEN H F, et al. Deciphering pathological behavior of pediatric medullary thyroid cancer from single-cell perspective[J]. PeerJ, 2023, 11:e15546. doi: 10.7717/peerj.15546 URL
[37]	GOLDFARB M, FRANCO A T. Survivorship, quality of life, and transition to adult care for pediatric and adolescent thyroid cancer survivors[J]. Thyroid, 2022, 32(12):1471-1476. doi: 10.1089/thy.2022.0407 pmid: 36193568
[38]	PEREZ M N, HALADA S, ISAZA A, et al. Health-related quality of life at diagnosis for pediatric thyroid cancer patients[J]. J Clin Endocrinol Metab, 2023, 108(5):e169-e177. doi: 10.1210/clinem/dgac648 URL